Journal article

Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations

Oivind Midttun, Despoina Theofylaktopoulou, Adrian McCann, Anouar Fanidi, David C Muller, Klaus Meyer, Arve Ulvik, Wei Zheng, Xiao-Ou Shu, Yong-Bing Xiang, Ross Prentice, Cynthia A Thomson, Mary Pettinger, Graham G Giles, Allison Hodge, Qiuyin Cai, William J Blot, Jie Wu, Mikael Johansson, Johan Hultdin Show all

The American Journal of Clinical Nutrition | OXFORD UNIV PRESS | Published : 2017

Grants

Awarded by NIH/National Cancer Institute (NCI)


Awarded by Australian National Health and Medical Research Committee


Awarded by US NCI


Awarded by US Public Health Service from the NCI, Department of Health and Human Services (DHHS)


Awarded by NIH


Awarded by Cancer Research UK grant


Awarded by Medical Research Council



Funding Acknowledgements

Supported by the NIH/National Cancer Institute (NCI) [grant 1U01CA155340-01; to the Lung Cancer Cohort Consortium (LC3)], the Australian National Health and Medical Research Committee (grant 1050198; to the LC3), the US NCI [grants R37 CA070867 and UM1 CA182910 (to the Shanghai Women's Health Study), R01 CA082729 and UM1 CA173640 (to the Shanghai Men's Health Study), and R01 CA092447 and U01 CA202979 (to the Southern Community Cohort Study). The Multiethnic Cohort Study was funded in part by grant U01 CA164973. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study is supported by the Intramural Research Program of the US NCI, NIH, and by US Public Health Service contract HHSN261201500005C from the NCI, Department of Health and Human Services (DHHS). The Campaign Against Cancer and Stroke and the Campaign Against Cancer and Heart Disease acknowledge the State of Maryland, the Maryland Cigarette Restitution Fund, and the National Program of Cancer Registries of the CDC for funds that support the collection and availability of the cancer registry data. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial is supported by contracts from the Division of Cancer Prevention and intramural research funding from the Division of Cancer Epidemiology and Genetics, NCI, US NIH, DHHS. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial was supported by the NIH (grants, UM1CA167552, UM1CA186107, P01CA87969, and R01CA49449). CR is supported by Cancer Research UK grant (C18281/A19169) and the Medical Research Council Integrative Epidemiology Unit at the University of Bristol with funds from the Medical Research Council (MC_UU_12013/2) and the University of Bristol. This is an open access article distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/)